Cargando…
Costs and financial feasibility of malaria elimination
The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the economics of elimination and analyse a central component of that framework—pote...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Lancet Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044845/ https://www.ncbi.nlm.nih.gov/pubmed/21035839 http://dx.doi.org/10.1016/S0140-6736(10)61355-4 |
_version_ | 1782198785796997120 |
---|---|
author | Sabot, Oliver Cohen, Justin M Hsiang, Michelle S Kahn, James G Basu, Suprotik Tang, Linhua Zheng, Bin Gao, Qi Zou, Linda Tatarsky, Allison Aboobakar, Shahina Usas, Jennifer Barrett, Scott Cohen, Jessica L Jamison, Dean T Feachem, Richard GA |
author_facet | Sabot, Oliver Cohen, Justin M Hsiang, Michelle S Kahn, James G Basu, Suprotik Tang, Linhua Zheng, Bin Gao, Qi Zou, Linda Tatarsky, Allison Aboobakar, Shahina Usas, Jennifer Barrett, Scott Cohen, Jessica L Jamison, Dean T Feachem, Richard GA |
author_sort | Sabot, Oliver |
collection | PubMed |
description | The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the economics of elimination and analyse a central component of that framework—potential short-term to medium-term financial savings. After a review that showed a dearth of existing evidence, the net present value of elimination in five sites was calculated and compared with effective control. The probability that elimination would be cost-saving over 50 years ranged from 0% to 42%, with only one site achieving cost-savings in the base case. These findings show that financial savings should not be a primary rationale for elimination, but that elimination might still be a worthy investment if total benefits are sufficient to outweigh marginal costs. Robust research into these elimination benefits is urgently needed. |
format | Text |
id | pubmed-3044845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Lancet Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-30448452011-03-14 Costs and financial feasibility of malaria elimination Sabot, Oliver Cohen, Justin M Hsiang, Michelle S Kahn, James G Basu, Suprotik Tang, Linhua Zheng, Bin Gao, Qi Zou, Linda Tatarsky, Allison Aboobakar, Shahina Usas, Jennifer Barrett, Scott Cohen, Jessica L Jamison, Dean T Feachem, Richard GA Lancet Series The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the economics of elimination and analyse a central component of that framework—potential short-term to medium-term financial savings. After a review that showed a dearth of existing evidence, the net present value of elimination in five sites was calculated and compared with effective control. The probability that elimination would be cost-saving over 50 years ranged from 0% to 42%, with only one site achieving cost-savings in the base case. These findings show that financial savings should not be a primary rationale for elimination, but that elimination might still be a worthy investment if total benefits are sufficient to outweigh marginal costs. Robust research into these elimination benefits is urgently needed. Lancet Publishing Group 2010-11-06 /pmc/articles/PMC3044845/ /pubmed/21035839 http://dx.doi.org/10.1016/S0140-6736(10)61355-4 Text en © 2010 Elsevier Ltd. All rights reserved. This document may be redistributed and reused, subject to certain conditions (http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0) . |
spellingShingle | Series Sabot, Oliver Cohen, Justin M Hsiang, Michelle S Kahn, James G Basu, Suprotik Tang, Linhua Zheng, Bin Gao, Qi Zou, Linda Tatarsky, Allison Aboobakar, Shahina Usas, Jennifer Barrett, Scott Cohen, Jessica L Jamison, Dean T Feachem, Richard GA Costs and financial feasibility of malaria elimination |
title | Costs and financial feasibility of malaria elimination |
title_full | Costs and financial feasibility of malaria elimination |
title_fullStr | Costs and financial feasibility of malaria elimination |
title_full_unstemmed | Costs and financial feasibility of malaria elimination |
title_short | Costs and financial feasibility of malaria elimination |
title_sort | costs and financial feasibility of malaria elimination |
topic | Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044845/ https://www.ncbi.nlm.nih.gov/pubmed/21035839 http://dx.doi.org/10.1016/S0140-6736(10)61355-4 |
work_keys_str_mv | AT sabotoliver costsandfinancialfeasibilityofmalariaelimination AT cohenjustinm costsandfinancialfeasibilityofmalariaelimination AT hsiangmichelles costsandfinancialfeasibilityofmalariaelimination AT kahnjamesg costsandfinancialfeasibilityofmalariaelimination AT basusuprotik costsandfinancialfeasibilityofmalariaelimination AT tanglinhua costsandfinancialfeasibilityofmalariaelimination AT zhengbin costsandfinancialfeasibilityofmalariaelimination AT gaoqi costsandfinancialfeasibilityofmalariaelimination AT zoulinda costsandfinancialfeasibilityofmalariaelimination AT tatarskyallison costsandfinancialfeasibilityofmalariaelimination AT aboobakarshahina costsandfinancialfeasibilityofmalariaelimination AT usasjennifer costsandfinancialfeasibilityofmalariaelimination AT barrettscott costsandfinancialfeasibilityofmalariaelimination AT cohenjessical costsandfinancialfeasibilityofmalariaelimination AT jamisondeant costsandfinancialfeasibilityofmalariaelimination AT feachemrichardga costsandfinancialfeasibilityofmalariaelimination |